Phenominer Database Results (83 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Average Type Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
WF.WKY-(D7Uwm25-D7Rat128)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Sanders J, et al., PLoS One. 2011;6(5):e19891. Epub 2011 May 18. mammary gland integrity trait female 155 days-160 days 43 7.2 null 0.46 3.0 in vivo visual assessment 0 DMBA oral gavage 105 days 66063 654
WF.COP-(D7Rat39-D7Uwm12)/1Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Sanders J, et al., PLoS One. 2011;6(5):e19891. Epub 2011 May 18. mammary gland integrity trait female 155 days-160 days 16 2.4 null 0.4 1.6 in vivo visual assessment 0 DMBA oral gavage 105 days 66065 654
SS-Chr 5BN/Mcwi percentage of study population developing mammary tumors during a period of time 7,12-dimethyltetraphene (DMBA) (65 g/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 13 54.0 % manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 11493 86
SS/JrHsdMcwi post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 40 79.8 d 0.59 3.71 manual palpation method 0 DMBA oral gavage 105 days 200ng DMBA/10 ml seasme oil 65568 86
SS-Chr 14BN/Mcwi post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 46.69 d 1.09 4.06 manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 65570 86
WKY/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Lan H, et al., Genetics 2001 Jan;157(1):331-9 mammary gland integrity trait female 169 days-174 days 17 0.0 null necropsy 0 3X3 mm diameter or larger 11741 141
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Samuelson DJ, et al., Carcinogenesis 2003 Sep;24(9):1455-60 mammary gland integrity trait female 155 days-160 days 50 6.9 null 0.4 2.83 unspecified method 0 3X3 mm diameter or larger 11743 142
WF.WKY-(D5Rat26-D5Uwm42)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Samuelson DJ, et al., Carcinogenesis 2003 Sep;24(9):1455-60 mammary gland integrity trait female 155 days-160 days 29 5.7 null 0.6 3.23 unspecified method 0 3X3 mm diameter or larger 11745 142
SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 14 3.93 null 0.64 2.39 manual palpation method 0 DMBA oral gavage 133 days 11355 74
SS.BN-(D6Rat149-D6Rat18)/Mcwi ratio of deaths related to DMBA toxicity to total study population during a period of time 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 total life span female 152 days-162 days 15 80.0 % necropsy 0 DMBA oral gavage 105 days ratio of deaths related to DMBA toxicity to total study population during a period of time (CMO:0003809) 65576 86
SS.BN-(D6Rat149-D6Got171)/Mcwi ratio of deaths related to DMBA toxicity to total study population during a period of time 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 total life span female 152 days-162 days 15 40.0 % necropsy 0 DMBA oral gavage 105 days ratio of deaths related to DMBA toxicity to total study population during a period of time (CMO:0003809) 65577 86
WF.WKY-(D5Uwm67-D5Uwm98)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 35 3.2 null 0.4 2.37 in vivo visual assessment 0.0 0 70296 653
WF.WKY-(D5Uwm76-D5Uwm92)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 58 4.8 null 0.4 3.05 in vivo visual assessment 0.0 0 70304 653
WF.WKY-(D5Uwm82-D5Uwm91)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 58 3.4 null 0.3 2.28 in vivo visual assessment 0.0 0 70312 653
SPRD.WKY-(D10Rat91-D10Rat135)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 25 9.24 null 0.65 3.25 manual palpation method 0 DMBA oral gavage 133 days 11357 74
SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 4.86 null 0.7 2.63 necropsy 0 DMBA oral gavage 105 days necropsy 65573 86
Crl:CD(SD) post-insult time to mammary tumor formation maternal milk (for 20 days) and vehicle control condition (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) Jenkins S, et al., Environ Health Perspect. 2009 Jun;117(6):910-5. doi: 10.1289/ehp.11751. Epub 2009 Jan 7. mammary gland integrity trait female 0 days-365 days 32 median 65.0 d manual palpation method 0.0 0 76267 1558
WF.WKY-(D7Rat171-D7Rat128)/2Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Sanders J, et al., PLoS One. 2011;6(5):e19891. Epub 2011 May 18. mammary gland integrity trait female 155 days-160 days 32 3.9 null 0.46 2.6 in vivo visual assessment 0 DMBA oral gavage 105 days 66061 654
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 186 days-191 days 46 7.61 null 0.07 0.45 necropsy 0 DMBA oral gavage 0 necropsy 11342 73
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 99 days-104 days 46 45.91 d 0.19 1.27 manual palpation method 0 DMBA oral gavage 0 11345 73
SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm mammary tumor growth rate 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 107 days-128 days 14 0.62 cm/week 0.02 0.08 unspecified method 0.0 DMBA oral gavage 0 the first 3 weeks of tumor growth 11347 73
SPRD.WKY-(D5Rat190-D5Rat114)(D18Rat102-D18Rat44)/Ibmm mammary tumor growth rate 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 36 0.37 cm/week 0.03 0.18 unspecified method 0 DMBA oral gavage 0 the first 3 weeks of tumor growth 11349 74
SPRD/Ztm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 17 10.89 null 0.43 1.77 manual palpation method 0 DMBA oral gavage 133 days 11354 74
SPRD.WKY-(D5Rat190-D5Rat114)(D18Rat102-D18Rat44)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 33 5.0 null 0.44 2.53 manual palpation method 0 DMBA oral gavage 133 days 11358 74
SS-Chr 3BN/Mcwi percentage of study population developing mammary tumors during a period of time 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 29.0 % manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 65566 86
SS.BN-(D6Rat149-D6Arb3)/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 4.77 null 0.64 2.39 necropsy 0 DMBA oral gavage 105 days necropsy 65571 86
WF.WKY-(D5Wox7-D5Uwm37)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Samuelson DJ, et al., Carcinogenesis 2003 Sep;24(9):1455-60 mammary gland integrity trait female 155 days-160 days 13 1.1 null 0.3 1.08 unspecified method 0 3X3 mm diameter or larger 11744 142
COP/OlaHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Haag JD, et al., Cancer Res 2003 Sep 15;63(18):5808-12 mammary gland integrity trait female 155 days-160 days 16 0.25 null 0.1 0.4 necropsy 0 3X3 mm diameter or larger 11747 143
SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 48.51 d 12.07 45.15 manual palpation method 0 DMBA oral gavage 105 days 200ng DMBA/10 ml seasme oil 65572 86
WF.WKY-(D5Uwm76-D5Uwm61)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 40 4.2 null 0.4 2.53 in vivo visual assessment 0.0 0 70297 653
WF.WKY-(D5Uwm78-D5Uwm93)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 27 5.0 null 0.5 2.6 in vivo visual assessment 0.0 0 70306 653
WF.COP-(D2Mit29-D2Rat201)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Haag JD, et al., Cancer Res 2003 Sep 15;63(18):5808-12 mammary gland integrity trait female 155 days-160 days 19 1.5 null 0.3 1.31 necropsy 0.0 0 3X3 mm diameter or larger 70168 143
Crl:CD(SD) post-insult time to mammary tumor formation maternal milk (for 20 days) and bisphenol A (25 ug/kg) (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) Jenkins S, et al., Environ Health Perspect. 2009 Jun;117(6):910-5. doi: 10.1289/ehp.11751. Epub 2009 Jan 7. mammary gland integrity trait female 0 days-365 days 34 median 53.0 d manual palpation method 0.0 0 76268 1558
WF.WKY-(D7Rat171-D7Rat128)/1Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Sanders J, et al., PLoS One. 2011;6(5):e19891. Epub 2011 May 18. mammary gland integrity trait female 155 days-160 days 17 3.5 null 0.61 2.5 in vivo visual assessment 0 DMBA oral gavage 105 days 66060 654
WF.WKY-(D7Rat171-D7Rat45)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Sanders J, et al., PLoS One. 2011;6(5):e19891. Epub 2011 May 18. mammary gland integrity trait female 155 days-160 days 28 3.4 null 0.4 2.1 in vivo visual assessment 0 DMBA oral gavage 105 days 66064 654
SS-Chr 9BN/Mcwi percentage of study population developing mammary tumors during a period of time 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 40 93.0 % manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 11495 86
SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm mammary tumor growth rate 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 16 0.65 cm/week 0.08 0.32 unspecified method 0 DMBA oral gavage 0 the first 3 weeks of tumor growth 11510 74
SS-Chr 6BN/Mcwi ratio of deaths related to DMBA toxicity to total study population during a period of time 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 total life span female 152 days-162 days 20 95.0 % necropsy 0 DMBA oral gavage 105 days ratio of deaths related to DMBA toxicity to total study population during a period of time (CMO:0003809) 65578 86
Crl:CD(SD) mammary tumor number maternal milk (for 20 days) and vehicle control condition (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) Jenkins S, et al., Environ Health Perspect. 2009 Jun;117(6):910-5. doi: 10.1289/ehp.11751. Epub 2009 Jan 7. mammary gland integrity trait female 0 days-365 days 32 2.84 null 0.31 1.75 manual palpation method 0.0 0 76264 1558
WF.WKY-(D7Rat51-D7Rat128)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Sanders J, et al., PLoS One. 2011;6(5):e19891. Epub 2011 May 18. mammary gland integrity trait female 155 days-160 days 23 8.0 null 0.85 4.1 in vivo visual assessment 0 DMBA oral gavage 105 days 66062 654
WF.COP-(D7Rat39-D7Uwm12)/2Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Sanders J, et al., PLoS One. 2011;6(5):e19891. Epub 2011 May 18. mammary gland integrity trait female 155 days-160 days 16 2.0 null 0.38 1.5 in vivo visual assessment 0 DMBA oral gavage 105 days 66066 654
SPRD/Ztm post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 97 days-102 days 48 43.8 d 0.13 0.9 manual palpation method 0 DMBA oral gavage 0 11343 73
SS-Chr 6BN/Mcwi percentage of study population developing mammary tumors during a period of time 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 20 20.0 % manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 11494 86
SPRD.WKY-(D10Rat91-D10Rat135)/Ibmm mammary tumor growth rate 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 33 0.53 cm/week 0.02 0.11 unspecified method 0 DMBA oral gavage 0 the first 3 weeks of tumor growth 11512 74
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Lan H, et al., Genetics 2001 Jan;157(1):331-9 mammary gland integrity trait female 169 days-174 days 21 7.3 null 0.98 4.5 necropsy 0 3X3 mm diameter or larger 11742 141
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 46 7.61 null 0.45 3.05 manual palpation method 0 DMBA oral gavage 133 days 11356 74
SS.BN-(D6Rat149-D6Arb3)/Mcwi ratio of deaths related to DMBA toxicity to total study population during a period of time 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 total life span female 152 days-162 days 14 57.0 % necropsy 0 DMBA oral gavage 105 days ratio of deaths related to DMBA toxicity to total study population during a period of time (CMO:0003809) 65575 86
WF.WKY-(D5Uwm76-D5Uwm98)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 26 3.8 null 0.4 2.04 in vivo visual assessment 0.0 0 70298 653
WF.WKY-(D5Uwm76-D5Got18)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 27 3.5 null 0.4 2.08 in vivo visual assessment 0.0 0 70300 653
WF.WKY-(D5Uwm67-D5Uwm81)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 26 8.3 null 0.7 3.57 in vivo visual assessment 0.0 0 70303 653
WF.WKY-(D5Uwm87-D5Uwm92)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 56 6.3 null 0.4 2.99 in vivo visual assessment 0.0 0 70309 653
WF.WKY-(D5Uwm77-D5Uwm91)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 12 3.8 null 0.8 2.77 in vivo visual assessment 0.0 0 70313 653
SS-Chr 9BN/Mcwi post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 40 58.31 d 0.85 5.39 manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 65567 86
SS-Chr 3BN/Mcwi post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 95.48 d 1.67 6.23 manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 11491 86
Crl:CD(SD) mammary tumor number maternal milk (for 20 days) and bisphenol A (250 ug/kg) (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) Jenkins S, et al., Environ Health Perspect. 2009 Jun;117(6):910-5. doi: 10.1289/ehp.11751. Epub 2009 Jan 7. mammary gland integrity trait female 0 days-365 days 24 5.0 null 0.88 4.31 manual palpation method 0.0 0 76266 1558
SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 186 days-191 days 14 3.93 null 0.17 0.64 necropsy 0 DMBA oral gavage 0 necropsy 11341 73
SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 107 days-112 days 14 53.4 d 0.64 2.4 manual palpation method 0 DMBA oral gavage 0 11344 73
SPRD/Ztm mammary tumor growth rate 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 97 days-118 days 48 0.7 cm/week 0.0 0.03 unspecified method 0.0 DMBA oral gavage 0 the first 3 weeks of tumor growth 11346 73
SS-Chr 16BN/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 13 6.31 null 1.61 5.79 necropsy 0 DMBA oral gavage 105 days necropsy 11504 86
WF mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (between 126 and 140 days) Shepel LA, et al., Genetics 1998 May;149(1):289-99 mammary gland integrity trait female 181 days-200 days 53 3.62 null 0.27 1.95 necropsy 0.0 DMBA oral gavage 126 days from 126 to 140 days 66100 689
WF.WKY-(D5Uwm78-D5Uwm98)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 32 2.8 null 0.3 1.7 in vivo visual assessment 0.0 0 70301 653
WF.WKY-(D5Uwm78-D5Uwm84)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 41 8.1 null 0.6 3.84 in vivo visual assessment 0.0 0 70307 653
WF.WKY-(D5Uwm85-D5Uwm92)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 51 3.9 null 0.3 2.14 in vivo visual assessment 0.0 0 70310 653
Crl:CD(SD) mammary tumor number maternal milk (for 20 days) and bisphenol A (25 ug/kg) (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) Jenkins S, et al., Environ Health Perspect. 2009 Jun;117(6):910-5. doi: 10.1289/ehp.11751. Epub 2009 Jan 7. mammary gland integrity trait female 0 days-365 days 34 3.82 null 0.43 2.51 manual palpation method 0.0 0 76265 1558
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm mammary tumor growth rate 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 99 days-120 days 46 0.79 cm/week 0.01 0.05 unspecified method 0.0 DMBA oral gavage 0 the first 3 weeks of tumor growth 11348 73
Crl:CD(SD) post-insult time to mammary tumor formation maternal milk (for 20 days) and bisphenol A (250 ug/kg) (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) Jenkins S, et al., Environ Health Perspect. 2009 Jun;117(6):910-5. doi: 10.1289/ehp.11751. Epub 2009 Jan 7. mammary gland integrity trait female 0 days-365 days 24 median 56.5 d manual palpation method 0.0 0 76269 1558
WF.WKY-(D5Uwm67-D5Uwm78)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 32 8.6 null 0.8 4.53 in vivo visual assessment 0.0 0 70299 653
WF.WKY-(D5Uwm78-D5Uwm84)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 29 8.8 null 0.7 3.77 in vivo visual assessment 0.0 0 70305 653
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 46 7.9 null 0.5 3.39 in vivo visual assessment 0.0 0 70314 653
SPRD/Ztm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 186 days-191 days 48 11.23 null 0.07 0.51 necropsy 0 DMBA oral gavage 0 necropsy 11340 73
SS/JrHsdMcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 40 2.45 null 0.21 1.32 necropsy 0 DMBA oral gavage 105 days necropsy 11488 86
SS-Chr 13BN/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 13 5.33 null 1.21 4.38 necropsy 0 DMBA oral gavage 105 days necropsy 11501 86
SPRD/Ztm mammary tumor growth rate 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 25 0.72 cm/week 0.04 0.2 unspecified method 0 DMBA oral gavage 0 the first 3 weeks of tumor growth 11509 74
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm mammary tumor growth rate 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 52 0.73 cm/week 0.03 0.22 unspecified method 0 DMBA oral gavage 0 the first 3 weeks of tumor growth 11511 74
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Haag JD, et al., Cancer Res 2003 Sep 15;63(18):5808-12 mammary gland integrity trait female 155 days-160 days 30 8.1 null 0.7 3.83 necropsy 0 3X3 mm diameter or larger 11746 143
SS.BN-(D6Rat149-D6Arb3)/Mcwi post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 52.37 d 1.32 4.94 manual palpation method 0 DMBA oral gavage 105 days 200ng DMBA/10 ml seasme oil 65574 86
WF mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Sanders J, et al., PLoS One. 2011;6(5):e19891. Epub 2011 May 18. mammary gland integrity trait female 155 days-160 days 19 7.3 null 0.83 3.6 in vivo visual assessment 0 DMBA oral gavage 105 days 66067 654
SS-Chr 19BN/Mcwi post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 44.03 d 0.41 1.54 manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 65569 86
SS-Chr 19BN/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 8.79 null 1.25 4.68 necropsy 0 DMBA oral gavage 105 days necropsy 11507 86
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Haag JD, et al., Cancer Res 2003 Sep 15;63(18):5808-12 mammary gland integrity trait female 155 days-160 days 29 6.3 null 0.5 2.69 necropsy 0.0 0 3X3 mm diameter or larger 70167 143
WF.WKY-(D5Uwm95-D5Uwm98)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 36 7.4 null 0.6 3.6 in vivo visual assessment 0.0 0 70302 653
WF.WKY-(D5Uwm88-D5Uwm92)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 58 6.9 null 0.6 4.57 in vivo visual assessment 0.0 0 70308 653
WF.WKY-(D5Uwm82-D5Uwm92)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 18 2.6 null 0.6 2.55 in vivo visual assessment 0.0 0 70311 653